Leisure Capital Management’s AbbVie ABBV Stock Holding History

Leisure Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-870	Closed	-$201K	–	151
2025 Q3	$201K	Buy	+870	New	+$177K	0.07%	142
2023 Q2	–	Sell	-2,130	Closed	-$339K	–	134
2023 Q1	$339K	Sell	2,130 -7,929	-79%	-$1.21M	0.19%	108
2022 Q4	$1.63M	Sell	10,059 -729	-7%	-$112K	0.84%	40
2022 Q3	$1.45M	Buy	10,788 +247	+2%	+$35.4K	0.88%	33
2022 Q2	$1.61M	Sell	10,541 -283	-3%	-$43.2K	0.84%	30
2022 Q1	$1.75M	Buy	10,824 +57	+0.5%	+$8.28K	0.89%	31
2021 Q4	$1.46M	Buy	10,767 +692	+7%	+$81.7K	0.67%	51
2021 Q3	$1.09M	Buy	10,075 +249	+3%	+$28.5K	0.59%	57
2021 Q2	$1.11M	Buy	+9,826	New	+$1.11M	0.62%	55
2018 Q4	–	Sell	-7,036	Closed	-$665K	–	127
2018 Q3	$665K	Buy	7,036 +330	+5%	+$31.3K	0.54%	62
2018 Q2	$621K	Buy	6,706 +2,030	+43%	+$198K	0.53%	65
2018 Q1	$443K	Buy	4,676 +2,272	+95%	+$250K	0.39%	71
2017 Q4	$232K	Buy	+2,404	New	+$227K	0.19%	90

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Leisure Capital Management's ABBV Position: Q4 2025 in Review

Leisure Capital Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 870 shares — an estimated $201K sold.

Leisure Capital Management first reported a position in ABBV in Q4 2017 and held it in 13 quarters. The position peaked at $1.75M in Q1 2022. 4,156 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Leisure Capital Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Leisure Capital Management sold 870 AbbVie shares in Q4 2025, an estimated $201K.
Leisure Capital Management first reported a position in AbbVie in Q4 2017 and held it in 13 quarters.
Leisure Capital Management's AbbVie position peaked at $1.75M in Q1 2022.
4,156 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Leisure Capital Management's 13F filing for Q4 2025, filed 27 Jan 2026.